Login / Signup

Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms.

Magdy El-SalhyJan Gunnar Hatlebakk
Published in: Digestive diseases and sciences (2024)
gov : NCT04236843).
Keyphrases
  • high intensity
  • early onset
  • irritable bowel syndrome
  • cell therapy
  • sleep quality
  • stem cells
  • drug induced
  • mesenchymal stem cells